Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Lung Cancer|Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: denileukin diftitox|BIOLOGICAL: recombinant fowlpox-CEA(6D)/TRICOM vaccine|BIOLOGICAL: therapeutic autologous dendritic cells
Sponsor: H. Kim Lyerly
Collaborators: National Cancer Institute (NCI)